A world leader in health care, Allergan has been bringing innovative pharmaceuticals
and medical products to people since 1950. We have a heritage of listening carefully
to patients and creating products that allow you to live life to its fullest potential.
In fields as diverse as eye care, neurosciences, dermatology and medical aesthetics,
our scientific excellence and discovery-to-development research has been helping
people to see more clearly,
move more freely and express themselves more fully.
We've led the way in the Science of Rejuvenation™ with products that
satisfy consumer needs and deliver real value. Our latest innovation, LATISSE®
(bimatoprost ophthalmic solution) 0.03%, is no different.
For more information about Allergan's portfolio of products, visit Allergan.com or click on the product links
below.
® mark owned by Allergan, Inc.
BOTOX® Cosmetic is approved for the temporary treatment of moderate to severe frown lines between the brows in people ages 18 to 65.
Important Safety Information
BOTOX® Cosmetic injections should not be given to people who have an infection where the physician proposes to inject. They should not be given to people who are known to be sensitive to any ingredient in BOTOX® Cosmetic.
Serious heart problems and serious allergic reactions have been reported rarely. If you think you are having an allergic reaction or other reactions, such as difficulty swallowing, speaking, or breathing, call your doctor immediately. The most common side effects following injection include temporary eyelid droop and nausea. Localized pain, infection, inflammation, tenderness, swelling, redness, and/or bleeding/bruising may be associated with the injection. Patients with certain neuromuscular disorders such as ALS, myasthenia gravis, or Lambert-Eaton syndrome may be at increased risk of serious side effects.
Additional Important Safety Information
The FDA on April 30, 2009, in its update to the early communication sent in 2008, gave the following recommendations:
- Understand that dosage strength (potency) expressed in "Units" or "U" are different among the botulinum toxin products; clinical doses expressed in units are not interchangeable from one botulinum toxin product to another.
- Be alert to and educate patients and caregivers about potential adverse events due to distant spread of botulinum toxin effects following local injections including: unexpected loss of strength or muscle weakness, hoarseness or trouble talking (dysphonia), trouble saying words clearly (dysarthria), loss of bladder control, trouble breathing, trouble swallowing, double vision, blurred vision and drooping eyelids.
- Understand that these adverse events have been reported as early as several hours and as late as several weeks after treatment.
- Advise patients to seek immediate medical attention if they develop any of these symptoms.
For BOTOX® Cosmetic full product information, please visit www.BOTOXCosmetic.com.